HeartWare Model 1101
FDA Device Recall #Z-0743-2023 — Class II — November 29, 2022
Recall Summary
| Recall Number | Z-0743-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 29, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Heartware, Inc. |
| Location | Miami Lakes, FL |
| Product Type | Devices |
| Quantity | 82 units |
Product Description
HeartWare Model 1101
Reason for Recall
Over time, the driveline cover may become hardened, creating difficulty or an inability to slide the cover back to access the driveline to controller connector. Access to the driveline connector may be delayed, which may result in patient harm from a prolonged pump stop, if an urgent driveline connection or controller issue needs to be addressed. In the event a hardened driveline cover is observed, contact your Medtronic field representative for further assessment and/or servicing.
Distribution Pattern
Worldwide distribution.
Lot / Code Information
Serial Numbers: HW1146, HW1205, HW1209, HW1247, HW1454, HW1533, HW1634, HW1688, HW1951, HW200, HW281, HW378, HW383, HW469, HW492, HW557, HW816, HW933, HW1091, HW1143, HW1144, HW1200, HW1242, HW1243, HW1244, HW1276, HW1280, HW1398, HW1403, HW1415, HW1437, HW1439, HW1456, HW1524, HW1553, HW1555, HW1637, HW1694, HW1697, HW1769, HW1816, HW1818, HW1963, HW198, hw209, HW229, HW257, HW290, HW304, HW310, HW321, HW323, HW433, HW467, HW482, HW488, HW536, HW562, HW568, HW578, HW581, HW590, HW591, HW610, HW635, HW645, HW678, HW795, HW796, HW798, HW801, HW819, HW825, HW827, HW888, HW889, HW922, HW978, HW107, HW210, HW216, HW526
Other Recalls from Heartware, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0478-2024 | Class II | PUMP 1103 HVAD (HeartWare Ventricular Assist De... | Oct 31, 2023 |
| Z-0482-2024 | Class II | HVAD (HeartWare Ventricular Assist Device) STER... | Oct 31, 2023 |
| Z-0481-2024 | Class II | PUMP 1104 HVAD (HeartWare Ventricular Assist De... | Oct 31, 2023 |
| Z-0479-2024 | Class II | PUMP 1104 HVAD (HeartWare Ventricular Assist De... | Oct 31, 2023 |
| Z-0475-2024 | Class II | HVAD (HeartWare Ventricular Assist Device) STER... | Oct 31, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.